Abstract
BackgroundThe impact of autoantibodies on the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) is not yet clear. Despite the fact that this information has...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have